A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Zou, Lijin ^a,b   Luo, Yonglun ^c   Chen, Muwan ^a,c   Wang, Gang ^d,e   Ding, Ming ^f   Petersen, Charlotte Christie ^c,g   Kang, Ran ^a   Dagnaes Hansen, Frederik ^c   Zeng, Yuanlin ^b   Lv, Nonghua ^b   Ma, Qing ^d,e   Le, Dang Q S ^a   Besenbacher, Flemming ^c   Bolund, Lars ^c   Jensen, Thomas G ^c   Kjems, Jørgen ^c   Pu, William T ^d,e   Bünger, Cody ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NANCHANG UNIVERSITY   (China)

^c AARHUS UNIVERSITY   (Denmark)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TISSUE SCAFFOLD;

ANIMAL; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINEAGE; CULTURE TECHNIQUE; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; OSTEOBLAST; PHENOTYPE; PHYSIOLOGY; PLURIPOTENT STEM CELL; TIME; TISSUE SCAFFOLD; ARTICLE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPE; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; RNA, MESSENGER; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 84880854310     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02243     Document Type: Article

References (34)

1. Horwitz, E. M. et al. Transplantability and therapeutic effects of bone marrowderived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5, 309-313 (1999).
2. Minguell, J. J., Erices, A. & Conget, P. Mesenchymal stem cells. Exp Biol Med (Maywood) 226, 507-520 (2001).
3. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
4. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
5. Bellin, M., Marchetto, M. C., Gage, F. H. & Mummery, C. L. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13, 713-726 (2012).
6. Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384 (2009).
7. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
8. Yakubov, E., Rechavi, G., Rozenblatt, S. & Givol, D. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 394, 189-193 (2010).
9. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945-949 (2008).
10. Teramura, T. et al. Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogram 12, 249-261 (2010).
11. Villa-Diaz, L. G. et al. Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells 30, 1174-1181 (2012).
12. Bilousova, G. et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 29, 206-216 (2011).
13. Lian, Q. et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113-1123 (2010).
14. Hwang, N. S. et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 105, 20641-20646 (2008).
15. Yen, M. L. et al. Efficient Derivation & Concise Gene Expression Profiling of Human Embryonic Stem Cell-Derived Mesenchymal Progenitors (EMPs). Cell Transplant 20, 1529-1545 (2011).
16. Yen, M. L. et al. Efficient Derivation & Concise Gene Expression Profiling of Human Embryonic Stem Cell-Derived Mesenchymal Progenitors (EMPs). Cell Transplant, 1529-1545 (2011).
17. Laurent, T. C., Laurent, U. B. & Fraser, J. R. The structure and function of hyaluronan: An overview. Immunol Cell Biol 74, A1-7 (1996).
18. LeGeros, R. Z. & Craig, R. G. Strategies to affect bone remodeling: osteointegration. J Bone Miner Res 8 Suppl 2, S583-596 (1993).
19. Wei, H. et al. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res 9, 87-100 (2012).
20. Brown, S. E., Tong, W. & Krebsbach, P. H. The derivation of mesenchymal stem cells from human embryonic stem cells. Cells, tissues, organs 189, 256-260 (2009).
21. Barberi, T., Willis, L. M., Socci, N. D. & Studer, L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS medicine 2, e161 (2005).
22. Lai, R. C., Choo, A. & Lim, S. K. Derivation and characterization of human ESC-derived mesenchymal stem cells. Methods Mol Biol 698, 141-150 (2011).
23. Choo, A. & Lim, S. K. Derivation of mesenchymal stem cells from human embryonic stem cells. Methods Mol Biol 690, 175-182 (2011).
24. Liu, Y., Goldberg, A. J., Dennis, J. E., Gronowicz, G. A. & Kuhn, L. T. One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One 7, e33225 (2012).
25. Chen, Y. S. et al. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem cells translational medicine 1, 83-95 (2012).
26. Gruenloh, W. et al. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 17, 1517-1525 (2011).
27. Jung, Y., Bauer, G. & Nolta, J. A. Concise review: Induced pluripotent stem cellderived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42-47 (2012).
28. Tsuji, O. et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107, 12704-12709 (2010).
29. Pierantozzi, E. et al. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev 20, 915-923 (2011).
30. Han, J. et al. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 30, 2746-2759 (2012).
31. Bobyn, J. D. et al. Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Joint Surg Am 86-A Suppl 2, 123-129 (2004).
32. Peter, S. J., Miller, M. J., Yasko, A. W., Yaszemski, M. J. & Mikos, A. G. Polymer concepts in tissue engineering. J Biomed Mater Res 43, 422-427 (1998).
33. Sun, H., Mei, L., Song, C., Cui, X. & Wang, P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 27, 1735-1740 (2006).
34. Guha, P., Morgan, J.W., Mostoslavsky, G., Rodrigues, N. P. & Boyd, A. S. Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells. Cell Stem Cell 12, 407-412 (2013).